These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33561512)

  • 1. Bio-inspired nanomaterials as novel options for the treatment of cardiovascular disease.
    Bose RJ; Ha K; McCarthy JR
    Drug Discov Today; 2021 May; 26(5):1200-1211. PubMed ID: 33561512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
    Mohamed NA; Marei I; Crovella S; Abou-Saleh H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of nanomaterials in the treatment of thrombus.
    Shen Y; Yu Y; Zhang X; Hu B; Wang N
    Drug Deliv Transl Res; 2024 May; 14(5):1154-1172. PubMed ID: 38006448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine in cardiovascular therapy: recent advancements.
    Binsalamah ZM; Paul A; Prakash S; Shum-Tim D
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):805-15. PubMed ID: 22894635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances of Cell Membrane Coated Nanoparticles in Treating Cardiovascular Disorders.
    Zhu C; Ma J; Ji Z; Shen J; Wang Q
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34198794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle: A Promising Player in Nanomedicine and its Theranostic Applications for the Treatment of Cardiovascular Diseases.
    Saeed S; Ud Din SR; Khan SU; Gul R; Kiani FA; Wahab A; Zhong M
    Curr Probl Cardiol; 2023 May; 48(5):101599. PubMed ID: 36681209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
    Soumya RS; Raghu KG
    J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine: A great boon for cardiac regenerative medicine.
    Choudhury P; Kandula N; Kosuru R; Adena SKR
    Eur J Pharmacol; 2024 Nov; 982():176969. PubMed ID: 39218342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicines for cardiovascular disease.
    Smith BR; Edelman ER
    Nat Cardiovasc Res; 2023 Apr; 2(4):351-367. PubMed ID: 39195953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell membrane coated nanoparticles: next-generation therapeutics.
    Narain A; Asawa S; Chhabria V; Patil-Sen Y
    Nanomedicine (Lond); 2017 Nov; 12(21):2677-2692. PubMed ID: 28965474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.
    Pala R; Anju VT; Dyavaiah M; Busi S; Nauli SM
    Int J Nanomedicine; 2020; 15():3741-3769. PubMed ID: 32547026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines: A Focus on Nanomaterials as Drug Delivery System with Current Trends and Future Advancement.
    Pandey J; Dubey R; Kate A; Prasad B; Sinha A; Mishra MS
    Drug Res (Stuttg); 2022 Sep; 72(7):355-366. PubMed ID: 35636435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.
    Arshad I; Kanwal A; Zafar I; Unar A; Mouada H; Razia IT; Arif S; Ahsan M; Kamal MA; Rashid S; Khan KA; Sharma R
    Environ Res; 2024 Feb; 242():117795. PubMed ID: 38043894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Managing Atherosclerosis via Nanomedicine.
    Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
    Small; 2018 Jan; 14(4):. PubMed ID: 29239134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances of Membrane-Cloaked Nanoplatforms for Biomedical Applications.
    Ai X; Hu M; Wang Z; Zhang W; Li J; Yang H; Lin J; Xing B
    Bioconjug Chem; 2018 Apr; 29(4):838-851. PubMed ID: 29509403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.
    Gu Y; Du L; Wu Y; Qin J; Gu X; Guo Z; Li Y
    Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano based drug delivery systems: recent developments and future prospects.
    Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
    J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of nanomedicine in cardiovascular diseases and stroke.
    Kim KS; Khang G; Lee D
    Curr Pharm Des; 2011; 17(18):1825-33. PubMed ID: 21631424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety assessment of nanomaterials: implications for nanomedicine.
    Nyström AM; Fadeel B
    J Control Release; 2012 Jul; 161(2):403-8. PubMed ID: 22306428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.